6.2. Sex Differences in Response to GLP-1 RA Therapy in Type 2 Diabetes and Obesity: Prefential Effects in Subcutaneous vs. Visceral Fat Depot. The gene discussed is GCG; the disease is type 2 diabetes mellitus.